ID   MARK1_RAT               Reviewed;         793 AA.
AC   O08678;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   02-OCT-2024, entry version 169.
DE   RecName: Full=Serine/threonine-protein kinase MARK1;
DE            EC=2.7.11.1;
DE            EC=2.7.11.26;
DE   AltName: Full=MAP/microtubule affinity-regulating kinase 1;
GN   Name=Mark1 {ECO:0000312|RGD:619882};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAB06294.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, PHOSPHORYLATION AT THR-215 AND SER-219, AND MUTAGENESIS OF
RP   LYS-89; THR-215 AND SER-219.
RC   STRAIN=Sprague-Dawley {ECO:0000312|EMBL:CAB06294.1};
RC   TISSUE=Brain {ECO:0000312|EMBL:CAB06294.1};
RX   PubMed=9108484; DOI=10.1016/s0092-8674(00)80208-1;
RA   Drewes G., Ebneth A., Preuss U., Mandelkow E.-M., Mandelkow E.;
RT   "MARK - a novel family of protein kinases that phosphorylate microtubule-
RT   associated proteins and trigger microtubule disruption.";
RL   Cell 89:297-308(1997).
RN   [2]
RP   FUNCTION, ACTIVITY REGULATION, PHOSPHORYLATION AT THR-215 AND SER-219, AND
RP   MUTAGENESIS OF THR-215 AND SER-219.
RX   PubMed=14517247; DOI=10.1093/emboj/cdg447;
RA   Timm T., Li X.Y., Biernat J., Jiao J., Mandelkow E., Vandekerckhove J.,
RA   Mandelkow E.M.;
RT   "MARKK, a Ste20-like kinase, activates the polarity-inducing kinase
RT   MARK/PAR-1.";
RL   EMBO J. 22:5090-5101(2003).
RN   [3]
RP   FUNCTION IN PHOSPHORYLATION OF DCX.
RX   PubMed=14741102; DOI=10.1016/s0896-6273(03)00843-2;
RA   Schaar B.T., Kinoshita K., McConnell S.K.;
RT   "Doublecortin microtubule affinity is regulated by a balance of kinase and
RT   phosphatase activity at the leading edge of migrating neurons.";
RL   Neuron 41:203-213(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-444, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Serine/threonine-protein kinase (By similarity). Involved in
CC       cell polarity and microtubule dynamics regulation. Phosphorylates DCX,
CC       MAP2 and MAP4. Phosphorylates the microtubule-associated protein
CC       MAPT/TAU (By similarity). Involved in cell polarity by phosphorylating
CC       the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS
CC       motifs, causing detachment from microtubules, and their disassembly.
CC       Involved in the regulation of neuronal migration through its dual
CC       activities in regulating cellular polarity and microtubule dynamics,
CC       possibly by phosphorylating and regulating DCX. Also acts as a positive
CC       regulator of the Wnt signaling pathway, probably by mediating
CC       phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3)
CC       (PubMed:14517247, PubMed:14741102, PubMed:9108484).
CC       {ECO:0000250|UniProtKB:Q9P0L2, ECO:0000269|PubMed:14517247,
CC       ECO:0000269|PubMed:14741102, ECO:0000269|PubMed:9108484}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:9108484};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:9108484};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[tau protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [tau protein]; Xref=Rhea:RHEA:12801, Rhea:RHEA-COMP:13701, Rhea:RHEA-
CC         COMP:13702, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.26;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[tau protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[tau protein]; Xref=Rhea:RHEA:53904, Rhea:RHEA-COMP:13703,
CC         Rhea:RHEA-COMP:13704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.26;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on Thr-215. Inhibited
CC       by phosphorylation at Ser-219. {ECO:0000269|PubMed:14517247}.
CC   -!- SUBUNIT: Interacts with MAPT/TAU. {ECO:0000250|UniProtKB:Q9P0L2}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:9108484}. Cytoplasm {ECO:0000250|UniProtKB:Q9P0L2}.
CC       Cell projection, dendrite {ECO:0000250|UniProtKB:Q9P0L2}. Note=Appears
CC       to localize to an intracellular network.
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and spleen and at lower
CC       levels in kidney and skeletal muscle. {ECO:0000269|PubMed:9108484}.
CC   -!- DOMAIN: The UBA domain does not seem to bind ubiquitin and ubiquitin-
CC       like and might play a role in regulating the enzyme conformation and
CC       localization. Activation of the kinase activity following
CC       phosphorylation at Thr-208 is accompanied by a conformational change
CC       that alters the orientation of the UBA domain with respect to the
CC       catalytic domain (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The KA1 domain mediates binding to phospholipids and targeting
CC       to membranes. Binds phosphatidic acid (PA), phosphatidylserine (PtdSer)
CC       and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylation at Thr-613 by PRKCZ/aPKC in polarized epithelial
CC       cells inhibits the kinase activity (By similarity). Phosphorylated at
CC       Thr-215 by STK11/LKB1 in complex with STE20-related adapter-alpha
CC       (STRADA) pseudo kinase and CAB39. Phosphorylation at Thr-215 by TAOK1
CC       activates the kinase activity, leading to phosphorylation and
CC       detachment of MAPT/TAU from microtubules. Phosphorylation at Ser-219 by
CC       GSK3-beta (GSK3B) inhibits the kinase activity. {ECO:0000250,
CC       ECO:0000269|PubMed:14517247, ECO:0000269|PubMed:9108484}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z83868; CAB06294.1; -; mRNA.
DR   RefSeq; NP_446399.1; NM_053947.1.
DR   AlphaFoldDB; O08678; -.
DR   SMR; O08678; -.
DR   BioGRID; 250617; 1.
DR   STRING; 10116.ENSRNOP00000003198; -.
DR   iPTMnet; O08678; -.
DR   PhosphoSitePlus; O08678; -.
DR   PaxDb; 10116-ENSRNOP00000003198; -.
DR   GeneID; 117016; -.
DR   KEGG; rno:117016; -.
DR   UCSC; RGD:619882; rat.
DR   AGR; RGD:619882; -.
DR   CTD; 4139; -.
DR   RGD; 619882; Mark1.
DR   VEuPathDB; HostDB:ENSRNOG00000002339; -.
DR   eggNOG; KOG0586; Eukaryota.
DR   HOGENOM; CLU_000288_157_5_1; -.
DR   InParanoid; O08678; -.
DR   OrthoDB; 5475340at2759; -.
DR   PhylomeDB; O08678; -.
DR   PRO; PR:O08678; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000002339; Expressed in frontal cortex and 20 other cell types or tissues.
DR   ExpressionAtlas; O08678; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0070300; F:phosphatidic acid binding; ISS:UniProtKB.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0001786; F:phosphatidylserine binding; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0051654; P:establishment of mitochondrion localization; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0001764; P:neuron migration; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0050773; P:regulation of dendrite development; ISO:RGD.
DR   GO; GO:0010975; P:regulation of neuron projection development; ISO:RGD.
DR   GO; GO:0150052; P:regulation of postsynapse assembly; ISO:RGD.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd12196; MARK1-3_C; 1.
DR   CDD; cd14072; STKc_MARK; 1.
DR   CDD; cd14405; UBA_MARK1; 1.
DR   Gene3D; 1.10.8.10; DNA helicase RuvA subunit, C-terminal domain; 1.
DR   Gene3D; 3.30.310.80; Kinase associated domain 1, KA1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR028375; KA1/Ssp2_C.
DR   InterPro; IPR001772; KA1_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR049508; MARK1-4_cat.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR015940; UBA.
DR   PANTHER; PTHR24346; MAP/MICROTUBULE AFFINITY-REGULATING KINASE; 1.
DR   PANTHER; PTHR24346:SF21; SERINE_THREONINE-PROTEIN KINASE MARK1; 1.
DR   Pfam; PF02149; KA1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00627; UBA; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF103243; KA1-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50032; KA1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Cell projection; Cytoplasm; Cytoskeleton;
KW   Kinase; Lipid-binding; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Wnt signaling pathway.
FT   CHAIN           1..793
FT                   /note="Serine/threonine-protein kinase MARK1"
FT                   /id="PRO_0000086300"
FT   DOMAIN          60..311
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          329..370
FT                   /note="UBA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT   DOMAIN          744..793
FT                   /note="KA1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00565"
FT   REGION          1..40
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          377..499
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          517..697
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        22..40
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        381..423
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        444..459
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        485..499
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        517..563
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        586..614
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        679..697
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        182
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H0K1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         66..74
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H0K1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         89
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000269|PubMed:9108484"
FT   MOD_RES         5
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P0L2"
FT   MOD_RES         208
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P0L2"
FT   MOD_RES         215
FT                   /note="Phosphothreonine; by LKB1 and TAOK1"
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:9108484"
FT   MOD_RES         219
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:9108484"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHJ5"
FT   MOD_RES         390
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHJ5"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHJ5"
FT   MOD_RES         403
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P0L2"
FT   MOD_RES         423
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHJ5"
FT   MOD_RES         444
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHJ5"
FT   MOD_RES         588
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P0L2"
FT   MOD_RES         613
FT                   /note="Phosphothreonine; by PKC/PRKCZ"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         666
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHJ5"
FT   MUTAGEN         89
FT                   /note="K->R: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:9108484"
FT   MUTAGEN         215
FT                   /note="T->A: Abolishes activation of serine/threonine-
FT                   protein kinase activity and only basal activity remains."
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:9108484"
FT   MUTAGEN         215
FT                   /note="T->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:9108484"
FT   MUTAGEN         215
FT                   /note="T->E: Induces an increase of the basal
FT                   serine/threonine-protein kinase activity."
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:9108484"
FT   MUTAGEN         219
FT                   /note="S->A,E: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:9108484"
FT   MUTAGEN         219
FT                   /note="S->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:9108484"
SQ   SEQUENCE   793 AA;  88235 MW;  C5BCCACE0BB9A0A3 CRC64;
     MSARTPLPTV NERDTENHTS VDGYTETHIP PTKSSSRQNI PRCRNSITSA TDEQPHIGNY
     RLQKTIGKGN FAKVKLARHV LTGREVAVKI IDKTQLNPTS LQKLFREVRI MKILNHPNIV
     KLFEVIETEK TLYLVMEYAS GGEVFDYLVA HGRMKEKEAR AKFRQIVSAV QYCHQKCIVH
     RDLKAENLLL DADMNIKIAD FGFSNEFTVG NKLDTFCGSP PYAAPELFQG KKYDGPEVDV
     WSLGVILYTL VSGSLPFDGQ NLKELRERVL RGKYRVPFYM STDCENLLKK LLVLNPIKRG
     SLEQIMKDRW MNVGHEEEEL KPYSEPELDL NDAKRIDIMV TMGFARDEIN DALVSQKYDE
     VMATYILLGR KPPEFEGGES LSSGNLCQRS RPSSDLNNST LQSPAHLKVQ RSISANQKQR
     RFSDHAGPSI PPAVSYTKRP QANSVESEQK EEWDKDTARR LGSTTVGSKS EVTASPLVGP
     DRKKSSAGPS NNVYSGGSMT RRNTYVCERS TDRYAALQNG RDSSLTEMSA SSMSSTGSTV
     ASAGPSARPR HQKSMSTSGH PIKVTLPTIK DGSEAYRPGT AQRVPAASPS AHSISASTPD
     RTRFPRGSSS RSTFHGEQLR ERRSAAYSGP PASPSHDTAA LAHARRGTST GIISKITSKF
     VRRDPSEGEA SGRTDTARGS SGEPKDKEEG KEAKPRSLRF TWSMKTTSSM DPNDMVREIR
     KVLDANTCDY EQRERFLLFC VHGDARQDSL VQWEMEVCKL PRLSLNGVRF KRISGTSIAF
     KNIASKIANE LKL
//
